Category: News
-
Atuka 进驻北美最大的城市创新中心
In a hugely significant moment for Atuka, we have completed the move into our new offices and facilities in North America’s largest urban innovation hub, MaRS Discovery District in downtown Toronto. Last week, we took a moment to celebrate and enjoy our new surroundings, which include a wide view of the centre’s magnificent atrium from…
-
Atuka 发布关于基因疗法未来的最新白皮书
Building on Atuka’s pioneering work in Parkinson’s disease and other neurodegenerative disorders, this paper lays out the transformative potential of gene therapy.
-
宣布与 Kannalife Sciences 和 Michael J. Fox 基金会达成150万美元合作项目
The grant will fund preclinical research of Kannalife Science’s KLS-13019, a synthetic cannabinoid therapeutic which offers great promise for Parkinson’s disease.
-
Atuka 欢迎新董事会成员伊恩-伦诺克斯（Ian Lennox
Atuka 在帕金森研究领域的传统基础上不断拓展，我们期待着伦诺克斯作为一位在本行业拥有数十年创新经验的开拓型管理者所做出的贡献。